Moving into the cloud: a summary from a European Bioanalysis forum workshop on introducing cloud applications in bioanalytical laboratories.


Journal

Bioanalysis
ISSN: 1757-6199
Titre abrégé: Bioanalysis
Pays: England
ID NLM: 101512484

Informations de publication

Date de publication:
30 Oct 2024
Historique:
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: aheadofprint

Résumé

In this manuscript, we summarize the discussions and key messages from developed in the e-environment team of the European Bioanalysis forum, which were the basis of a subsequent workshop on cloud applications in a regulated bioanalysis lab environment, hosted by the European Bioanalysis Forum e-environment team at their 16th Open Symposium in Barcelona, Spain in November 2023. The purpose of our discussions is to provide further insight and understanding on the status of having cloud applications implemented in a regulated bioanalysis laboratory and the challenges experienced. The discussions highlight the importance of cross functional collaboration during the entire process of cloud implementation and some of the uncertainties in the different functions' roles and responsibilities.

Identifiants

pubmed: 39474816
doi: 10.1080/17576180.2024.2416357
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-4

Auteurs

Cecilia Arfvidsson (C)

AstraZeneca, Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, Gothenburg, Sweden.

Katja Zeiser (K)

Nuvisan GmbH, Bioanalysis, 89231, Neu-Ulm, Germany.

Lars-Ole Andresen (LO)

Novo Nordisk A/S, Non-Clinical & Clinical Assay Sciences, 2760, Måløv, Denmark.

David Van Bedaf (DV)

J&J Innovative Medicine, Preclinical Sciences & Translational Safety, 2340, Beerse, Belgium.

Harm Buddiger (H)

Genmab BV, Bioanalytical Science, 3584 CT, Utrecht, The Netherlands.

Christopher Jones (C)

AstraZeneca, Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, Cambridge, CB21 6GH, United Kingdom.

Werner Schauerte (W)

GSK R&D, SG1 2NY, Stevenage, United Kingdom.

Jens Sigh (J)

Novo Nordisk A/S, Non-Clinical & Clinical Assay Sciences, 2760, Måløv, Denmark.

Milan Vagaday (M)

Celerion Switzerland AG, Bioanalytical Services, 8320, Fehraltorf, Switzerland.

Philip Timmerman (P)

European Bioanalysis Forum vzw (EBF), Havenlaan 86c b204, 1000, Brussel, Belgium.

Classifications MeSH